Metraipolis › archive › dc_3ddd5fae5324
Safety recommendations for ALK tyrosine kinase inhibitors in non-small cell lung cancer: evidence from FAERS and CVARDD real-world databases — Europe PMC PMID:41959908
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41959908
- DOI
- 10.3389/fonc.2026.1728791
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T23:04:38.329Z
- SHA-256 of the archived text
ecfb640e9c46ec38629fa1ad15f2ca0c9bfeb534ca0f8eda20137c3b67f39d07- Stable URL of this page
https://metraipolis.com/documento/dc_3ddd5fae5324
How to cite
Safety recommendations for ALK tyrosine kinase inhibitors in non-small cell lung cancer: evidence from FAERS and CVARDD real-world databases — Europe PMC PMID:41959908 — Europe PMC (en), https://europepmc.org/article/MED/41959908 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ddd5fae5324 (Metraipolis archive dc_3ddd5fae5324, sha256 ecfb640e9c46ec38629fa1ad15f2ca0c9bfeb534ca0f8eda20137c3b67f39d07)
BibTeX
@misc{dc3ddd5fae5324,
title = {Safety recommendations for ALK tyrosine kinase inhibitors in non-small cell lung cancer: evidence from FAERS and CVARDD real-world databases — Europe PMC PMID:41959908},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41959908},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ddd5fae5324; sha256 ecfb640e9c46ec38629fa1ad15f2ca0c9bfeb534ca0f8eda20137c3b67f39d07},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41959908. Agents can read the archived copy with the MCP tool read_document.